Overview A Study in Adult Patients With Major Depressive Disorder Status: Completed Trial end date: 2011-03-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess whether LY2216684 is superior to placebo in the treatment of adult patients with major depressive disorder. Phase: Phase 2/Phase 3 Details Lead Sponsor: Eli Lilly and Company